These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option? Hirt-Minkowski P, Schaub S, Mayr M, Schifferli JA, Dickenmann M, Frémeaux-Bacchi V, Steiger J. Nephrol Dial Transplant; 2009 Nov; 24(11):3548-51. PubMed ID: 19633317 [Abstract] [Full Text] [Related]
8. Actual and future strategies for transplantation in atypical HUS associated with mutations in factor H. Riedl M, Rosales A, Zimmerhackl LB, Jungraithmayr T. Pediatr Transplant; 2011 May; 15(3):225-8. PubMed ID: 21492349 [No Abstract] [Full Text] [Related]
9. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background. Bresin E, Daina E, Noris M, Castelletti F, Stefanov R, Hill P, Goodship TH, Remuzzi G, International Registry of Recurrent and Familial HUS/TTP. Clin J Am Soc Nephrol; 2006 Jan; 1(1):88-99. PubMed ID: 17699195 [Abstract] [Full Text] [Related]
10. Transplantation in atypical hemolytic uremic syndrome. Kavanagh D, Richards A, Goodship T, Jalanko H. Semin Thromb Hemost; 2010 Sep; 36(6):653-9. PubMed ID: 20865642 [Abstract] [Full Text] [Related]
11. Successful treatment of hemolytic uremic syndrome after liver-kidney transplantation. Gatti S, Arru M, Reggiani P, Como G, Rossi F, Fassati LR, Ponticelli C. J Nephrol; 2003 Sep; 16(4):586-90. PubMed ID: 14696763 [Abstract] [Full Text] [Related]
13. Membrane cofactor protein and factor I: mutations and transplantation. Kavanagh D, Goodship TH. Semin Thromb Hemost; 2006 Mar; 32(2):155-9. PubMed ID: 16575690 [Abstract] [Full Text] [Related]
14. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation. Tran H, Chaudhuri A, Concepcion W, Grimm PC. Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349 [Abstract] [Full Text] [Related]
18. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation. Davin JC, Gracchi V, Bouts A, Groothoff J, Strain L, Goodship T. Am J Kidney Dis; 2010 Apr; 55(4):708-11. PubMed ID: 19854549 [Abstract] [Full Text] [Related]